PTC Therapeutics | Kapitał Własny I Rezerwy



Equity Capital And Reserves Zmiana Data
Acadia Pharmaceuticals USD 732.79M 155.61M 2024-12
Alnylam Pharmaceuticals USD 115.43M 48.35M 2025-03
Amgen USD 6.21B 330M 2025-03
Biogen USD 16.98B 262.7M 2025-03
BioMarin Pharmaceutical USD 5.79B 135.47M 2025-03
Cytokinetics USD -135372000 121.46M 2024-12
Daiichi Sankyo JPY 1.62T 958M 2025-03
Gilead Sciences USD 19.33B 856M 2024-12
Incyte USD 3.67B 219.94M 2025-03
Ionis Pharmaceuticals USD 475.73M 112.62M 2025-03
Ironwood Pharmaceuticals USD -301245000 10.09M 2024-12
Novartis USD 44.05B 605M 2024-12
Pfizer USD 90.34B 2.14B 2025-03
PTC Therapeutics USD -185760000 912.31M 2025-03
Roche Holding CHF 36.16B 3.28B 2024-12
Sarepta Therapeutics USD 1.14B 385.02M 2025-03
TG Therapeutics USD 222.36M 30.21M 2024-12
Ultragenyx Pharmaceutical USD 144.25M 111.05M 2025-03
Vertex Pharmaceuticals USD 16.41B 778.7M 2024-12
Xencor USD 677.61M 46.22M 2024-12



PTC Therapeutics Kapitał Własny I Rezerwy - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.